These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38581546)

  • 21. [Analysis of treatment response and prognostic factors of T-LBL patients treated with pediatric-like ALL therapy following HSCT].
    Wang HT; Dong Y; Gao XT; Wan Z; Zhao YX; Liu YM; Liu L
    Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):387-393. PubMed ID: 32536135
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
    Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia.
    Meng T; Qi J; Zhu Y; Xu Y; Chen F; Xue S; Miao M; Chen S; Han Y; Tang X; Qiu H; Sun A; Wu D; Wang Y
    Hematol Oncol; 2021 Aug; 39(3):358-363. PubMed ID: 33521954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of Philadelphia Chromosome Karyotype and Allogeneic Hematopoietic Stem Cell Transplantation on Patients with Acute Lymphoblastic Leukemia].
    Wang Y; Xu XM; Zhang M; Wang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1397-1406. PubMed ID: 36208241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia].
    Zhu YX; Zhu MQ; Dai HP; Liu SN; Yin J; Li Z; Cui QY; Zhu XM; Wu DP; Tang XW
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1021-1025. PubMed ID: 32023734
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation].
    Chen X; Liu ZY; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; He Y; Wei JL; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):542-549. PubMed ID: 36709130
    [No Abstract]   [Full Text] [Related]  

  • 27. Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.
    Brammer JE; Saliba RM; Jorgensen JL; Ledesma C; Gaballa S; Poon M; Maziarz RT; Champlin RE; Hosing C; Kebriaei P
    Bone Marrow Transplant; 2017 Jan; 52(1):20-27. PubMed ID: 27618682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
    Candoni A; Rambaldi A; Fanin R; Velardi A; Arcese W; Ciceri F; Lazzarotto D; Lussana F; Olivieri J; Grillo G; Parma M; Bruno B; Sora F; Bernasconi P; Saccardi R; Foà R; Sessa M; Bresciani P; Giglio F; Picardi A; Busca A; Sica S; Perruccio K; Zucchetti E; Diral E; Iori AP; Colombo AA; Tringali S; Santarone S; Irrera G; Mancini S; Zallio F; Malagola M; Albano F; Carella AM; Olivieri A; Tecchio C; Dominietto A; Vacca A; Sorasio R; Orciuolo E; Risitano AM; Leotta S; Cortelezzi A; Mammoliti S; Oldani E; Bonifazi F;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2388-2397. PubMed ID: 31400502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
    Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant.
    Cao XY; Zhang JP; Zhao YL; Xiong M; Zhou JR; Lu Y; Sun RJ; Wei ZJ; Liu DY; Zhang X; Yang JF; Lu P
    Front Immunol; 2023; 14():1191382. PubMed ID: 37469510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
    Aygüneş U; Karagün BŞ; Şaşmaz I; Antmen AB
    Clin Transplant; 2024 May; 38(5):e15366. PubMed ID: 38775798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis.
    Wei H; Kuang P; Liu T
    Ann Hematol; 2020 Nov; 99(11):2619-2628. PubMed ID: 32960314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical outcomes of hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma].
    Xu LM; Li NN; Wang Z; Wu XX; Dong YJ; Fu XR; Liu Y; Hu LD; Li XF; Wang YN; Wu YM; Ren HY; Zhang MZ; Wang MH; Li YH; Huang WR
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):573-577. PubMed ID: 32397020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].
    Zhang YM; Zhang Y; Ni X; Gao L; Qiu HY; Zhang YS; Tang GS; Chen J; Zhang WP; Wang JM; Yang JM; Hu XX
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):16-22. PubMed ID: 32023749
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China.
    Ding J; Su Y; Ruan Y; Li N; Meng Q; Yang J; Chen L; Liu C
    Hematology; 2024 Dec; 29(1):2310960. PubMed ID: 38323781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.
    Lu Y; Zhang JP; Zhao YL; Xiong M; Sun RJ; Cao XY; Wei ZJ; Zhou JR; Liu DY; Yang JF; Zhang X; Lu DP; Lu P
    Front Immunol; 2022; 13():1066748. PubMed ID: 36685540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma.
    Li Z; Zhang B; Fan X; Gui R; Yu F; Wang J; Zhang Y; Zhou K; Liu Y; Li Y; Ding J; Song Y; Zhou J
    Front Oncol; 2023; 13():1193237. PubMed ID: 37546390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.
    Mo XD; Wang Y; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Qin YZ; Liu KY; Huang XJ
    Oncologist; 2018 Nov; 23(11):1349-1357. PubMed ID: 30076280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.